Current role
Chad J. Swanson, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Chad J. Swanson, Ph.D.
Prothena Corp Public Ltd Co reported in an 8-K filed September 27, 2024 that Chad J. Swanson, Ph.D. was appointed Chief Development Officer.
“Chad J. Swanson, Ph.D., appointed Chief Development Officer and will lead clinical development and medical functions”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-09-27–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Prothena Corp Public Ltd Co
Other people whose current roles at this company are on record from its filings.
- Gene Kinney CEO, Board Member
- Lars G. Ekman Chairman, Board Member
- Brandon S. Smith COO, Board Member
- Brandon Smith Board Member
- Carol D. Karp Board Member
- Daniel G. Welch Board Member
- Dennis J. Selkoe Board Member
- Helen S. Kim Board Member
- Richard T. Collier Board Member
- Sanjiv K. Patel, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.